Lamivudine for Chronic Hepatitis B

Trial Profile

Lamivudine for Chronic Hepatitis B

Phase of Trial: Phase II

Latest Information Update: 25 Jul 2016

At a glance

  • Drugs Lamivudine (Primary)
  • Indications Glomerulonephritis; Hepatitis B; Hepatitis D; Periarteritis nodosa
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 Jul 2016 New trial record
    • 03 Jul 2016 Results published in the Alimentary Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top